A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores
about
Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virusHuman monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxEvaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.Anthrax vaccination strategiesRecombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challengeAnthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.Polymeric Materials for Gene Delivery and DNA VaccinationGenetic vaccines for anthrax based on recombinant adeno-associated virus vectorsInduction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.Lipid and polymeric carrier-mediated nucleic acid delivery.Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4.Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugationAn anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine.Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults.DNA vaccines for biodefense.Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunityEpitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.Most of the Dominant Members of Amphibian Skin Bacterial Communities Can Be Readily CulturedEnhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge.Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthraxMarkedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporationAn adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimenPast, imminent and future human medical countermeasures for anthrax.Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthraxElectroporation-based DNA immunisation: translation to the clinic.Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodiesVaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infectionA DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines.Anthrax lethal toxin and the induction of CD4 T cell immunity.Anthrax vaccines: present status and future prospects.Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design.Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.Murine macrophages kill the vegetative form of Bacillus anthracisVaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.
P2860
Q24658311-0A1A442C-59C4-4BD8-B84A-1355844A5624Q24682011-BAE07AAD-F809-44C6-8C57-C5A3E8298F45Q24795118-FDE95102-F1CC-43A0-AFA6-4A1EEFCF6529Q28392248-F0502DA9-D6A6-4C2A-9410-802492E5EAB8Q33258307-B5CD55A0-D7F5-42DC-BA52-A7DED976332FQ33360151-D25D315D-AAE5-4BCC-BBB5-6A50D0ED1666Q33505445-CA51552E-85F7-4760-85F8-09D779F2F10CQ33565296-38EC0166-04F7-4266-A32D-5A55A4173EFAQ33713243-8D623F93-A45C-4968-9886-E1700E7F1DC1Q34033557-5C0DD498-AD7A-4A24-84CF-43C125815CF1Q34155795-F63CF445-D738-452C-AEA1-3034EF0A3783Q34334441-06621EDF-B5E8-493F-8DA8-323099614448Q34389283-6C3053ED-63F0-4C31-AAE1-17384D9764F0Q34433313-461B5804-3E38-4A5B-99D2-DB5C900DAEE8Q34521758-342D13D9-13CC-4E41-8F00-B7E254660625Q34582387-3C205B29-BC52-4C54-8BBD-53C9733D9670Q34614260-9C36B990-D1E9-4D9F-84D6-73ACF401AB94Q35161514-330DEE20-74A1-4E5D-B5FA-5B0BC1ABC240Q35341887-0B7DA03C-DC67-4A7E-AD64-54D333DD2DB9Q35688502-15A22EF1-836F-46B3-B97B-618233F7B3D5Q35796747-AB892730-0E3A-4673-9ACC-C97E3C0B33C6Q36143517-E08CD092-9611-48E7-BEBF-A95A3C87D61BQ36155940-A2A43B17-0ACD-486C-A06C-B3326401B7EEQ36428352-CC2E4319-822A-452B-9175-BA3A1C6DAAF0Q36504794-801FDA2A-9DB8-4203-98C8-A2BA22CB9CC3Q36565152-0C8FA589-10EA-498E-9DD9-BADE8FA72952Q36668524-64EF323D-1F64-428A-B033-19F0E24DF27CQ36981658-A5E2B392-AF12-468F-93F2-BCECB7A04A33Q37033046-9BDF3D37-D07F-41F1-893A-448ED641D322Q37127506-BC94BA27-6652-4187-9127-6F2000A0E7E6Q37258250-D9D3D27C-DCCC-4E29-8241-0CFDCB18A4B9Q37351412-9B84BC15-94D1-453C-ACFB-BA6ABEB0D486Q37813689-DD71B0A6-47C2-478B-98D7-4FD8A70E94FAQ38060730-D71BB852-3060-4AA7-8260-32F9F37BF15EQ38132268-E534A792-284F-4D5A-AF2C-A5B114841F2EQ38268596-0E9BC3EF-C215-4F9A-8534-57126B99C252Q39143157-01A2A56E-B48B-4F73-A97D-2A9BDD34097DQ39205816-D714739E-F1ED-424F-8A2F-28927FEC0B4CQ39394058-5898E65E-247F-4486-B1CC-342849FE4E07Q42079721-93D12BE8-56E6-4EE2-AEE4-488EAA946F96
P2860
A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A cationic lipid-formulated pl ...... nst aerosolized anthrax spores
@en
A cationic lipid-formulated pl ...... st aerosolized anthrax spores.
@nl
type
label
A cationic lipid-formulated pl ...... nst aerosolized anthrax spores
@en
A cationic lipid-formulated pl ...... st aerosolized anthrax spores.
@nl
prefLabel
A cationic lipid-formulated pl ...... nst aerosolized anthrax spores
@en
A cationic lipid-formulated pl ...... st aerosolized anthrax spores.
@nl
P2093
P2860
P356
P1476
A cationic lipid-formulated pl ...... nst aerosolized anthrax spores
@en
P2093
A Mateczun
D Galloway
G Hermanson
K Brenneman
P2860
P304
13601-13606
P356
10.1073/PNAS.0405557101
P407
P577
2004-09-01T00:00:00Z